1. Comparisons of the activity and kinetics of the branched-chain 2-oxo acid dehydrogenase in cultured skin fibroblasts from normal and classical maple-syrup-urine disease (MSUD) subjects provide a kinetic explanation for the enzyme defect. 2. In the intact cell assays, normal fibroblasts demonstrated hyperbolic kinetics with 3-methyl-2-oxol 1-14Clbutyrate as a substrate. Intact fibroblasts from four classical MSUD patients showed no decarboxylation over a substrate concentration range of 0.25 to 5.0mM, and thiamin (4mM) was without effect. 3. The overall reaction of the multienzyme complex was efficiently reconstituted by using a disrupted-cell system. Normals again showed typical hyperbolic kinetics at the 2-oxo acid concentrations of 0.1 to 5 mM. The Vmax and apparent Km values were 0.10 + 0.02 m-unit/mg of protein and 0.05-0.1 mM respectively, with 3-methyl-2-oxobutyrate. In contrast, classical MSUD patients exhibited sigmoidal kinetics (Hill coefficient, 2.5) with activity approaching 40-60% of the normal value at 5 mM substrate. The K0 svalues from the Hill plots for MSUD patients were 4-7 mm. 4. The E1 (branched-chain 2-oxo acid decarboxylase) component of the multienzyme complex was measured in disrupted-particulate preparations. Normals again showed hyperbolic kinetics with the 2-oxo acid, whereas MSUD preparations exhibited sigmoidal kinetics with the activity of El strictly dependent on substrate concentration. Apparent Km or K05 were 0.1 and 1.0 mM for normal and MSUD subjects respectively. 5. Measurements of E2 (dihydrolipoyl transacylase) and E3 (dihydrolipoyl dehydrogenase) in MSUD preparations showed them to be in the normal range. 6. The above data suggest a defect in the E1 step of branched-chain 2-oxo acid dehydrogenase in classical MSUD patients.
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MSUD is an autosomal recessive inborn error of metabolism in which the primary defect is that of oxidative decarboxylation of the branched-chain 2-oxo acids derived from the three branched-chain amino acids leucine, isoleucine and valine. MSUD has been classified into classical, variant and intermittent types, based on the rapidity of onset and severity of the disease as well as tolerance for dietary protein (Dancis et al., 1967 (Dancis et al., , 1972 .
Dancis and his co-workers demonstrated that both the classical and variant forms of MSUD have a deficiency in the branched-chain 2-oxo acid Abbreviations used: MSUD, maple-syrup-urine disease; TPP, thiamin pyrophosphate: E1 branched-chain 2-oxo acid decarboxylase; E2, dihydrolipoyl transacylase; E3, dihydrolipoyl dehydrogenase; KO5, concentration of substrate for half-maximal saturation.
Vol. 200 dehydrogenase (EC 1.2.4.4) activity that is expressed both in peripheral leucocyte preparations (Dancis et al., 1963) and in skin fibroblast cultures (Dancis et al., 1969 (Dancis et al., , 1972 . By using fibroblast cultures and radioactive branched-chain amino acids labelled in the carboxy carbon atom, they showed a clear correlation between the degree of deficiency in decarboxylation of the branched-chain amino acid in the cell cultures from different patients with MSUD, and the clinical history and dietary protein tolerance (Dancis et al., 1972) . Other laboratories preferred to use radioactive branched-chain 2-oxo acid as substrate, thereby avoiding the interposed step of transamination (Seegmiller & Westall, 1967; Wendel et al., 1973 Wendel et al., , 1975 Danner & Elsas, 1975) . At low branched-chain 2-oxo acid concentration (0.5 mM), good correlation was found between the clinical 0306-3283/81/100059-09$01.50/1 (9) 1981 The Biochemical Society phenotype and decarboxylation of branched-chain 2-oxo acid (Wendel et al., 1975; Dancis et al., 1977) , but at higher substrate concentrations (1.5-15.0mM) most fibroblast cultures derived from MSUD patients showed considerable decarboxylation with overlap between normal and MSUD subjects.
A major controversy existed concerning the number of species of branched-chain 2-oxo acid dehydrogenase. Recently, Pettit et al. (1978) and Danner et al. (1979) have purified branched-chain 2-oxo acid dehydrogenase to homogeneity from bovine tissues, and demonstrated it to be a single multienzyme complex consisting of three components. The first component, E1, is a decarboxylase, the second, E2, is a dihydrolipoyl transacylase, and the third, E3, dihydrolipoyl dehydrogenase. In the present paper, the activity of the branched-chain 2-oxo acid dehydrogenase overall reaction is measured in intact and in disrupted skin fibroblasts derived from normal subjects and patients with the classical form of MSUD. These investigations clearly describe a kinetic basis for the enzyme deficiency in MSUD and clarify several ambiguities in the literature. Secondly, assays were developed to measure separately each of the three steps of the branched-chain 2-oxo acid dehydrogenase overall reaction. These assays are sensitive enough to be used with cultured fibroblasts. By using a particulate preparation derived from normal cells and from fibroblasts of two patients with classical MSUD, the enzymic lesion in these patients was demonstrated to involve the El component.
Experimental

Cell culture
Normal fibroblasts were grown from skin biopsies in monolayer culture in Waymouth's medium containing 5% foetal-and 5% newborn-calf serum and antibiotics (penicillin, 50 units; streptomycin, 50,ug/ml; kanamycin, 30,ug/ml All patients except CoBa have been previously reported (Dancis et al., 1977) (Meister, 1953) . The radioactive purity of the 2-oxo (1-14C)-labelled acid was found to be >99% by ascending t.l.c. (Benson et al., 1950) . The labelled 2-oxo acid was maintained at pH4 and stored at -200C.
Protein determination
Fibroblasts were precipitated with 7.5% trichloroacetic acid and dissolved in 0.6M-NaOH containing 2% sodium desoxycholate, and protein was determined by the Lowry method (Lowry et al., 1951) , with bovine serum albumin as standard.
Intact cell assay
Fibroblasts were harvested with a medium containing 0.02% EDTA and 0.04% trypsin, in Puck's saline A without glucose (Marcus et al., 1956 ). The harvested cells were washed by centrifugation (650g) once with a Krebs-Ringer phosphate buffer (Krebs, 1933) containing 20% foetal-calf serum and once with the buffer only. The washed cells (1 x 106, equivalent to 0.3 mg of protein, in 0.05 ml of Krebs buffer) were suspended in 0.35 ml of medium containing 0.25ml of the Krebs-Ringer phosphate buffer, pH7.4, 0.005ml of thiamin hydrochloride (100mg/ml) and 3-methyl-2-oxo[ 1-'4C]butyrate (sp. radioactivity 172 c.p.m./nmol). Incubation medium containing equivalent numbers of boiled normal cells were used as a blank. The blank value was within 10-20% of the total sample counts that ranged from 600 to 1200 c.p.m. with normal fibroblasts depending on substrate concentrations. The assay was carried out in a Kontes pear-shaped flask (10ml volume) capped with a serum stopper. Incubations were for up to 80min at 350C with 14CO2 collected in a centre well containing 0.1 ml of 2M-NaOH.
After stopping the reaction with 0.05 ml of 15% trichloroacetic acid, the incubation was allowed to continue for 1 h to recover residual '4CO2 from the incubation medium. At the end of the incubation, the NaOH solution was transferred to lOml of scintillation cocktail to determine radioactivity. The scintillation cocktail contained in 1 litre: 640ml of methanol, 320ml of toluene, 20ml of phenethyl-amine, 20 ml of glycerol, 6 g of methylbenzethonium chloride, 6g of 2,5-diphenyloxazole and 120mg of 1,4-bis-(4-methyl-5-phenyloxazol-2-yl)benzene. Activity was expressed as nmol of 14C02 evolved/min per mg of cell protein (equivalent to m-units/mg of cell protein).
Assayfor branched-chain 2-oxo acid dehydrogenase
The overall reaction catalysed by the multienzyme complex was assayed by using disrupted fibroblast suspensions. The assay was essentially that described by Danner & Elsas (1975) , except for the way the cells were disrupted and the inclusion of calf serum in the assay to protect the enzyme from proteolysis. The fibroblasts were harvested and washed as previously described and suspended in the Krebs-Ringer buffer (1 x 106/0.05 ml). The cell suspension was rapidly frozen in a Revco refrigerator (-75 IC) and kept for 15 h or longer and then thawed for assays. Fibroblasts thus treated were fully disrupted as observed under a phase-contrast microscope. The activity of the frozen cells was stable for at least 2 months at -75 'C. The assay mixture contained 50 mM-Tris/HCl, pH 7.5, 0.2 mM-EDTA, 0.35 mM-MgCI2, 0.2 mM-CoA, 0.2 mM-NAD+, 0.2 mM-TPP, 1.4% foetal-calf serum, the disrupted cell suspension (1 x 106 cells equivalent to 0.3mg protein) in 0.05 ml of Krebs buffer and 3-methyl-2-oxo[ 1-_4Clbutyrate (sp. radioactivity 172 c.p.m./ nmol) in a final volume of 0.37 ml. The blank value with Krebs buffer was within 10-20% of the total sample counts, which ranged from 300 to 800c.p.m. with normal fibroblasts, depending on substrate concentrations. The incubation and remaining procedure were the same as in the intact cell assay. Preparation ofparticulatefraction Particulate fraction of skin fibroblasts was prepared by a modification (Mackall & Lane, 1977) of the digitonin-treatment method (Zuurendonk & Tager, 1974) . Cultured fibroblasts were harvested as described above, resuspended in an iso-osmotic buffer (0.22 M-mannitol/0.07 M-sucrose/0.005 M-4-morpholinepropanesulphonic acid. pH 7.5) containing 1 mg of digitonin/mI (B. L. Lemke and Co., Lodi, NJ, U.S.A.) at 0°C for exactly 60s. The cells were rapidly pelleted with an Eppendorf microcentrifuge 5412 at 12800g for 60s. The pellet was washed three times with the above iso-osmotic buffer without digitonin, resuspended in the same medium (2mg of protein/ml) and stored at -750C.
Assayfor the E, component
The radiochemical assay was modified from a previous spectrophotometric procedure with K3Fe(CN)6 as an electron acceptor (Gubler, 1961; Sullivan et al., 1976 Assayfor the E2 component Activity of the E2 component was measured by using a model reaction similar to the one for the transacetylase of pyruvate dehydrogenase complex (Butterworth et al., 1975) . In this model reaction exogenous dihydrolipoamide substituted for the protein-bound dihydrolipoyl moiety and 1-'4C-labelled acyl-CoA was used as a substrate. The assay mixture contained 50 mM-potassium phosphate, pH 7.4, 2 mM-dihydrolipoamide, 0.4 mM-2-methyl[ 1-'4Clpropionyl-CoA (sp. radioactivity 400 c.p.m./nmol) and frozen-and-thawed fibroblasts (in 0.05 ml of Krebs buffer), in a final volume of 0.37ml. The mixture was incubated at 350C for up to 20min. To stop the reaction, 0.75ml of benzene was added and the mix?ure was vortex-mixed for 10s to extract the labelled S-(2-methylpropionyl)dihydrolipoamide. A 0.2 ml portion of the benzene layer was withdrawn and the radioactivity was measured in a Beckman liquid-scintillation spectrometer. The values were approximately 250 c.p.m. after a 20 min incubation. Dihydrolipoamide was omitted from the control tubes (blank value approx. 60 c.p.m.). Activity was expressed as nmol of S-(2-methylpropionyl)dihydrolipoamide formed per min/mg of protein (equivalent to m-units/mg of protein). Assayfor the E3 component
The E3 component was assayed in the direction of lipoamide reduction as described previously (Stumpf & Parks, 1978) . The assay mixture contained 50mM-potassium phosphate, pH 6.5, 1.5 mM-EDTA, 1 mM-DL-lipoamide, 0.2 mM-NADH, 0.15% Triton X-100 and cell suspension [(1-5)x jQs cells]. The reaction was followed spectrophotometrically at 37°C and 340nm. Blanks without lipoamide were used. Activity was expressed as nmol of NADH oxidized per min/mg of protein (m-units/mg of protein).
Assays for pyruvate and 2-oxoglutarate dehydrogenase complexes Activity of dichloroacetate-stimulated pyruvate dehydrogenase complex was assayed by the method of Sheu et al. (1981) . The assay for 2-oxoglutarate dehydrogenase complex was the same as that for Vol. 200 branched-chain 2-oxo acid dehydrogenase except that 0.5mM-2-oxo[1-_4Clglutarate (sp. radioactivity 1 100c.p.m./nmol) was used as a substrate and 2.7 mM-CaCl2 and 2.7mM-MgCl2 were also included in the assay mixture. Incubation for the latter assay was at 350C for 10min.
Miscellaneous
Dihydrolipoamide was prepared from DL-lipoamide by the procedure of Reed et al. (1958) .
2-Methyll 1-'4Clpropionyl-CoA was synthesized enzymically by using medium-chain fatty acid:CoA ligase (AMP-forming) (EC 6.2.1.2) from bovine liver (D. T. Chuang, W.-L. Niu & R. P. Cox, unpublished work). Lactate dehydrogenase was assayed as described by Kornberg (1955 Fig. 2 . Comparison of decarboxvlation rates for 3-methvl-2-oxol l-_4Clbutvrate in intact and disrupted normalfibroblasts All assays were carried out at 2 mM-2-oxo (1-'4C)-labelled acid and 350C using the same cell suspension. Branched-chain 2-oxo acid dehydrogenase activity in intact cells (-) was measured as described in Fig. 1 . Branched-chain 2-oxo acid dehydrogenase activity in disrupted cells (A) was reconstituted as described in the Experimental section. The 0 represents activity in disrupted cells incubated with the 2-oxo (1-_4C)-labelled acid and 4mM-thiamin/HCI in Krebs-Ringer phosphate buffer but without added cofactors and metal ions.
Enzyme activities in maple-syrup-urine-disease fibroblasts system, have no measurable branched-chain 2-oxo acid dehydrogenase activity. These findings suggest that mitochondria, where the enzyme resides, are leaky or ruptured during the preparation of disrupted cells by freezing and thawing.
Kinetics of the overall branched-chain 2-oxo acid dehydrogenase reaction Disrupted normal fibroblasts (Tu and Pa) showed hyperbolic Michaelis-Menten kinetics over the substrate range 0.1-5.0mM similar to those observed with the intact cell assay. The Vmax and apparent Km values were 0.10 + 0.02 m-unit/mg of cell protein and 0.05-0.1 mm respectively with 3-methyl-2-oxo-1-'4Clbutyrate as substrate (Fig. 3) . In contrast, disrupted fibroblast preparations from mutant cells (DaMa and GM-612; Fig. 3 ) revealed sigmoidal kinetics with essentially no activity in the 0 to 1 mm range, but approaching 40-60% of the normal value at 5 mm concentration of 2-oxo acid. Hill plots (Fig. 3 insert) 106 cells) were treated with digitonin (1 mg/ml), and the particulate fraction was separated from the cytosol by centrifugation (see the Experimental section for details). Lactate dehydrogenase was assayed as described by Kornberg (1955) . Dihydrolipoyl dehydrogenase (E3) and branched-chain 2-oxo acid dehydrogenase (overall reaction) activities were measured as described in the Experimental section. fraction was free of cytosol using lactate dehydrogenase as a marker and that virtually all the E3 component and the branched-chain 2-oxo acid dehydrogenase were located in this particulate fraction.
Enzyme
Determination of E1 activity and the kinetics of the reaction in particulate fractions prepared from normal fibroblasts (Pa) and from two strains of MSUD fibroblasts (DaMa and GM-6 12) is shown in Fig. 4 . Kinetic patterns of the normal and the two MSUD patients are quite similar to those observed with the overall reaction. That is, particulate fractions from a normal (Pa) subject (Fig. 4) show hyperbolic kinetics over the substrate concentration range 0.1-5.0 mm, whereas both mutant cell strains exhibit sigmoidal kinetics with the decarboxylase activity within the normal range at high substrate concentrations (5mM). Hill plots (Fig. 4 insert) yielded a Ko.5 value of approx. 1.Omm for patients DaMa and GM-612, which was 10-fold higher than the apparent Km value of 0.1 mm for the normal subject. Hill coefficients of 1.5-1.7 for MSUD subjects were calculated from the plots.
E2 and E3 activities
To determine if the enzymic lesion in a classical MSUD patient was confined to the first step, E1 of the multienzyme complex, the activities of the other two components, E2 and E3 were measured. 
Discussion
A central question in defining the biochemical basis of MSUD has been the number of branchedchain 2-oxo acid dehydrogenases involved in the oxidative decarboxylation of the three branchedchain 2-oxo acids. The concordant decrease of activity for all three substrates in fibroblasts from patients with classical (grade I), variant (grade II) and intermittent (grade III) forms of the disease argues for a single enzyme complex (Dancis et al., 1972; Danner & Elsas, 1975) . Recently, Pettit et al. (1978) and Danner et al. (1979) have purified the branched-chain 2-oxo acid dehydrogenase from bovine kidney and liver respectively to homogeneity and have shown unequivocally that a single mitochondrial multienzyme complex oxidatively Vol. 200 decarboxylates all three 2-oxo acids in bovine tissues. The activity ratios among the three substrates were essentially constant for both enzyme preparations throughout purification and Km values in the 30-50pM range were determined. Further, the three 2-oxo acids inhibit one another competitively with K; values similar to the respective Km values (Danner et al., 1978) .
On Fig. 1 ).
Our second approach to characterize the enzyme deficiency in MSUD was to develop a disrupted-cell system where relatively high activity of branchedchain 2-oxo acid dehydrogenase was reconstituted. Purified enzyme from fibroblasts is not available, because of low activity in cultured mutant cells and difficulties in obtaining sufficient quantities of cells to purify an intact multienzyme complex. Nonetheless, by using the disrupted-cell system, normal cells exhibited hyperbolic kinetics, and its apparent Km of 0.05-0.10mM was in the range of highly purified bovine branched-chain 2-oxo acid dehydrogenase (Pettit et al., 1978; Danner et al., 1979) . In contrast, the sigmoidal kinetics and K0.s values of 4 and 7 mM for patients DaMa and GM-612 respectively suggest a significant decrease in the enzyme's affinity for substrate.
The striking differences in decarboxylation of 2-oxo acid by MSUD fibroblasts between the intact and broken cell assays are probably expected. Intact mutant cells with high KO.5 values for substrate combined with putative membrane effects that limit availability of substrate in mitochondria probably account for the absence of branched-chain 2-oxo arid decarboxylation. The close correlations between the patient's phenotype and tolerance for dietary protein with the degree of enzyme deficiency observed in the intact cell assay (Wendel et al., 1975; Dancis et al., 1977) suggest that this system approximates the situation in vivo. On the other hand, the reconstituted disrupted-cell assay provides a more direct measurement of enzyme activities and the opportunity to study the substrate-dependent kinetics of mutant enzymes.
Our third approach was to separate the activity of the overall branched-chain 2-oxo acid dehydrogenase reaction into its individual steps and measure these in fibroblasts from normal subjects and patients with classical MSUD. The availability of these assays may be useful in defining more precisely genetic heterogeneity in MSUD (Lyons et al., 1973) . The ferricyanide electron-acceptor method (Gubler, 1961; Sullivan et al., 1976 ) permitted a functional isolation of the first El step from the overall reaction, and the use of radioactive substrate in the present study provided the sensitivity necessary to assay fibroblasts. The validity of the ferricyanide assay was demonstrated by its insensitivity to arsenite (1.5-mM) inhibition (Sullivan et al., 1976) and the low apparent Km of 0.026 mm for 3-methyl-2-oxobutyrate with disrupted rat liver mitochondria (results not shown). This Km value for El reaction is in good agreement with those of the overall reaction using the homogeneous bovine enzyme (Pettit et al., 1978; Danner et al., 1979) . The ferricyanide assay of El activity in classical MSUD fibroblasts showed altered kinetics similar to the overall reaction, suggesting that the enzymic abnormality is associated with the E1 step.
The E2 assays appeared to be specific in that the reaction was sensitive to arsenite inhibition (Sanadi et al., 1959) and was not catalysed by purified pyruvate dehydrogenase complex (results not shown). Results using this assay with disrupted fibroblasts showed similar E2 activity, in both control and classical patients. Activities of the E3 components were also measured and were in the normal range in both classical patients. The E3 component is believed to be a common moiety shared by pyruvate, 2-oxoglutarate and branchedchain 2-oxo acid dehydrogenase complexes (Sakurai et al., 1970; Koike & Koike, 1976) . A defect in this component has been reported to result in deficiencies in all three multienzymes (Robinson & Taylor, 1979) .
In summary, the present study provides a kinetic explanation for the enzyme deficiency in MSUD, and suggests that the enzymic lesion most likely involves the E1 component of branched-chain 2-oxo acid dehydrogenase. The molecular basis for the altered kinetics observed with patients' fibroblasts is unknown. An R = T equilibrium (Monod et al., 1965 ) with a shift towards the T state, resulting from a structural defect in the El component, is compatible with the positive co-operativity with substrate exhibited by the mutant enzyme. However, aberations in enzyme regulation, for example, a defect in the end-product inhibition (Pettit et al., 1978; Bremer & Davis, 1978; Parker & Randle, 1978) , or in the proposed phosphorylation-dephosphorylation cycle (Odessey, 1980a,b; Parker & Randle, 1980 
